SD HEALTHCARE

Leidos to Support Navy Health Research in $58M Deal

Leidos Inc. recently received a five-year, $57.8 million task order to perform work at Naval Health Research Center in San Diego.

With Drug Approval, Ionis Set to Compete with Alnylam

The U.S. Food and Drug Administration on Oct. 5 approved Ionis Pharmaceuticals’ drug for a potentially fatal genetic disorder, pitting the company against Alnylam Pharmaceuticals.

S.D. Sustainable Chemical Manufacturer Raises $90M

Genomatica, which manufactures plant-based chemicals, raised $90 million in an equity offering.

Tease photo

Biotechs Among Most Impacted by Gender Law

LEGAL: Women Often Bypassed On Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Tease photo

Medtechs Lead Life Science Stock Gains for Third Quarter

Medtechs led the way in stocks of public life science companies in San Diego during the third quarter.

Tease photo

MappBio Awarded $14.8M Contract for Sudan Virus Therapy

San Diego’s MappBio received a $14.8 million contract to advance a treatment for Sudan virus.

Biotechs Among Most Impacted by Law Requiring Women on Boards

LEGAL: Dearth of Women on Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Frances Arnold, an Illumina Board Member, Shares Nobel Prize

The board director of San Diego life sciences giant Illumina and professor at Caltech shared in the Nobel Prize for Chemistry.

Tease photo

Acadia and FDA Confident in Parkinson’s Psychosis Drug

Acadia Pharmaceuticals is flying higher after the U.S. Food and Drug Administration reaffirmed its drug in uncharacteristically public fashion.

VelosBio Lands $58M Round

VelosBio, a San Diego-based firm developing cancer drugs, received a $58 million Series A round, investor Arix Bioscience recently announced.

Careful Approach to CBD Sales Paying Off

CANNABIS: Products Tested; Co. Also Working on New Drug

CV Sciences has emerged as a major player of a burgeoning corner of the cannabis industry: hemp-derived cannabidiol.

Tease photo

Ra Medical Raises $66.3M in Trading Debut

Carlsbad’s Ra Medical Systems became a public company on Sept. 27, raising $66.3 million.

Life Sciences Reporter's Notebook: Life Sciences Loads Up on VC Dollars

In San Diego, life sciences dominates in early-stage investment. Looking at 2017 through this September — a 19-month period — San Diego-based life sciences companies pulled in $2.73 billion in venture capital, according to a recently released snapshot from JLL research. That represented 44.8 percent of venture capital in San Diego, more than the next three categories combined.

Tease photo

Tocagen Hires Head of Commercial Role

Tocagen, a San Diego company behind a cancer therapy that’s in a final-stage trial, is building up commercial operations.

Rady Children’s Launches Medi-Cal Pilot for Genetic Testing in Newborns

Rady Children’s Hospital recently announced its lead role in a state pilot program that will expand genome sequencing for critically ill newborns.